ROSEZ Stock Overview
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
DocMorris AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF34.38 |
| 52 Week High | CHF122.10 |
| 52 Week Low | CHF23.10 |
| Beta | 0.74 |
| 1 Month Change | -13.40% |
| 3 Month Change | -32.85% |
| 1 Year Change | -65.86% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| ROSEZ | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | -1.9% | 0.7% | 1.1% |
| 1Y | -65.9% | 11.0% | 1.9% |
Return vs Industry: ROSEZ underperformed the UK Consumer Retailing industry which returned 31.4% over the past year.
Return vs Market: ROSEZ underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| ROSEZ volatility | |
|---|---|
| ROSEZ Average Weekly Movement | 8.0% |
| Consumer Retailing Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: ROSEZ's share price has been volatile over the past 3 months.
Volatility Over Time: ROSEZ's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,283 | Walter Hess | corporate.docmorris.com/en |
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops.
DocMorris AG Fundamentals Summary
| ROSEZ fundamental statistics | |
|---|---|
| Market cap | CHF400.44m |
| Earnings (TTM) | -CHF171.11m |
| Revenue (TTM) | CHF1.61b |
0.2x
P/S Ratio-2.3x
P/E RatioIs ROSEZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ROSEZ income statement (TTM) | |
|---|---|
| Revenue | CHF1.61b |
| Cost of Revenue | CHF1.36b |
| Gross Profit | CHF245.63m |
| Other Expenses | CHF416.74m |
| Earnings | -CHF171.11m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 17, 2023
| Earnings per share (EPS) | -14.69 |
| Gross Margin | 15.27% |
| Net Profit Margin | -10.64% |
| Debt/Equity Ratio | 139.8% |
How did ROSEZ perform over the long term?
See historical performance and comparison